Effects of vitamin D supplementation on endothelial function: a systematic review and meta-analysis of randomised clinical trials

European Journal of Nutrition

Volumn 56, Issue 3, 2017, Pages 1095-1104

  Hussin, Azizah Mat ^a,b   Ashor, Ammar W ^a,c   Schoenmakers, Inez ^d   Hill, Tom ^e   Mathers, John C ^a   Siervo, Mario ^a,d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITI KUALA LUMPUR   (Malaysia)

^c MUSTANSIRIYAH UNIVERSITY   (Iraq)

^d MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular risk; Flow mediated dilation; Forearm blood flow; Nitric oxide; Pulse wave velocity; Vitamin D

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

APPLANATION TONOMETRY; ARTICLE; BODY MASS; COCHRANE LIBRARY; DATA EXTRACTION; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ECHOGRAPHY; EFFECT SIZE; EMBASE; ENDOTHELIAL FUNCTION; HEALTH STATUS; HUMAN; LASER DOPPLER FLOWMETRY; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLETHYSMOGRAPHY; PRACTICE GUIDELINE; PUBLISHING; QUALITATIVE ANALYSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCOPUS; SYSTEMATIC REVIEW; TONOMETRY; TREATMENT DURATION; TREND STUDY; VASCULAR ENDOTHELIUM; VITAMIN SUPPLEMENTATION; BLOOD; BLOOD PRESSURE; DIETARY SUPPLEMENT; DRUG EFFECTS; ENDOTHELIUM; FACTUAL DATABASE; METABOLISM;

BLOOD PRESSURE; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; ENDOTHELIUM; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84957545310     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-016-1159-3     Document Type: Article

References (68)

1. Dahlof B (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 105:3a–9a
2. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695
3. Higashi Y et al (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73:411–418
4. Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992
5. Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92:4–8
6. Brandenburg VM et al (2012) The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 225:253–263
7. Dalan R et al (2014) Vitamin D and the endothelium: basic, translational and clinical research updates. IJC Metab Endocr 4:4–17
8. Andrukhova O et al (2014) Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol 28:53–64
9. Liu S et al (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:2926–2932
10. Pittas AG et al (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650–656
11. Knekt P et al (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology (Cambridge, Mass) 19:666–671
12. Bajaj A et al (2014) Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS sleep study. J Clin Endocrinol Metab 99:3256–3262
13. Sollid ST et al (2014) No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care 37(8):2123–2131
14. Pittas AG et al (2010) Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 152:307–314
15. Breslavsky A et al (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32:970–975
16. 3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24:557–562
17. Sugden JA et al (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med J Br Diabet Assoc 25:320–325
18. Gepner AD et al (2012) A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS one 7:e36617 (Electronic Resource)
19. Hewitt NA et al (2013) Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol CJASN 8:1143–1149
20. Larsen T et al (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25:1215–1222
21. Longenecker CT et al (2012) Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 17:613–621
22. Marckmann P et al (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 27:3523–3531
23. Sokol SI et al (2012) The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med (United Kingdom) 17:394–404
24. Stricker H et al (2012) Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 44:307–312
25. Witham MD et al (2010) The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53:2112–2119
26. Witham MD et al (2012) The effect of vitamin D replacement on markers of vascular health in stroke patients—a randomised controlled trial. Nutr Metab Cardiovasc Dis 22:864–870
27. Beveridge LA, Witham MD (2013) Vitamin D and the cardiovascular system. Osteoporos Int 24:2167–2180
28. Witham MD et al (2013) Effects of vitamin D supplementation on markers of vascular function after myocardial infarction–a randomised controlled trial. Int J Cardiol 167:745–749
29. Witham MD et al (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 173:1672–1679
30. Yiu YF et al (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227:140–146
31. Stojanović M, Radenković M (2015) Vitamin D versus placebo in improvement of endothelial dysfunction: a meta-analysis of randomized clinical trials. Cardiovasc Ther 33:145–154
32. Siervo M et al (2011) Measurement of in vivo nitric oxide synthesis in humans using stable isotopic methods: a systematic review. Free Radic Biol Med 51:795–804
33. Higgins JPT, Green S (2008) Guide to the contents of a Cochrane protocol and review. In: Higgins JP, Green S (eds) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, Ltd, Chichester, UK, pp 51–79
34. Liberati A, et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
35. Crowther M et al (2010) Systematic review and meta-analysis methodology. Blood 116:3140–3146
36. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC
37. Cummings P (2011) Arguments for and against standardized mean differences (effect sizes). Arch Pediatr Adolesc Med 165:592–596
38. Higgins JPT, et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
39. Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 315:629–634
40. Witham MD et al (2013) Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK—a randomised controlled trial. Atherosclerosis 230:293–299
41. Harris RA, et al (2011) Vitamin D improves flow-mediated dilation in African American adults. FASEB J 24(5):557–562
42. Wu SH et al (2010) Effects of vitamin D supplementation on blood pressure. South Med J 103:729–737
43. Kassi E et al (2013) Role of vitamin D in atherosclerosis. Circulation 128:2517–2531
44. Somjen D et al (2000) Vitamin D analogs modulate the action of gonadal steroids in human vascular cells in vitro. Am J Hypertens 13:396–403
45. Molinari C et al (2011) 1alpha, 25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27:661–668
46. Aihara K et al (2006) Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo. Clin Calcium 16:1173–1179
47. Almirall J et al (2010) Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrol Dial Transplant 25:503–509
48. 3 in arterial blood pressure control. Polski Merkuriusz Lekarski 23:307–310
49. Chai W et al (2013) Effects of calcium and vitamin D supplementation on blood pressure and serumlipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial. Ann Epidemiol 23:564–570
50. Cosenso-Martin LN, Vilela-Martin JF (2011) Is there an association between vitamin D and hypertension? Recent Pat Cardiovasc Drug Discov 6:140–147
51. 3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258–261
52. Al Mheid I et al (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58:186–192
53. Nadir MA et al (2010) Vitamin D and cardiovascular prevention. Cardiovasc Ther 28:e5–e12
54. Grandi NC et al (2010) Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51:228–233
55. Song Y et al (2013) Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36:1422–1428
56. Williams S et al (2009) Vitamin D and chronic kidney disease. Ethn Dis 19(4 Suppl 5):S5-8–11
57. Ruggiero M, Pacini S (2009) Chronic kidney disease and vitamin D: how much is adequate? Kidney Int 76:931–933
58. Pittas AG et al (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029
59. 3. Cell Biochem Funct 20:227–232
60. 3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47:383–391
61. Nagpal S et al (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662–687
62. Siervo M et al (2011) Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA). Nutr Metab Cardiovasc Dis NMCD 21:1–10
63. Wortsman J et al (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693
64. Rodríguez-Rodríguez E et al (2009) Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity 17:778–782
65. Vilarrasa N et al (2007) Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 30:653–658
66. Blum M et al (2008) Vitamin D 3 in fat tissue. Endocrine 33:90–94
67. 3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95:1357–1364
68. Cashman KD et al (2014) Dietary vitamin D(2)–a potentially underestimated contributor to vitamin D nutritional status of adults? Br J Nutr 112:193–202